Biosimilar drugs breaking high-cost barrier to cancer immunotherapy
viaTimes of India24 Oct
Recent changes in cancer care in India show an increase in immunotherapy prescriptions due to affordable biosimilars. Doctors report that the availability of cheaper versions of nivolumab has improved patient access to treatment. Research indicates that lower doses may be effective for Indian…
Khabar Adda curates headlines like this across Top Stories, Entertainment, Bollywood, Hollywood, Crime and Politics from public RSS feeds. This page links out to Times of India's own reporting rather than reproducing it — the excerpt above comes from Times of India's own feed.
Read the full story on Times of India ↗